Product Information

IMVEXXY 10 MCG STARTER PACK is a brand product labeled by Mayne Pharma, priced at $27.0553 per EA under NDC 68308074818. Its NADAC has been published 72 times since Apr 9, 2025.

FDA first approved this application on May 29, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for IMVEXXY 10 MCG STARTER PACK has been published 72 times since Apr 9, 2025, and over the history we have for it it has risen 4.6%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.